PHASE I STUDIES Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination

Authors
Publication date
24 April 2020
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    CiteSeerX

    redirect
    oaioai:CiteSeerX.psu:10.1.1.1075....
    Last time updated on 07/12/2020